Your browser doesn't support javascript.
loading
Everolimus (RAD001) sensitizes prostate cancer cells to docetaxel by down-regulation of HIF-1α and sphingosine kinase 1.
Alshaker, Heba; Wang, Qi; Kawano, Yoshiaki; Arafat, Tawfiq; Böhler, Torsten; Winkler, Mathias; Cooper, Colin; Pchejetski, Dmitri.
Afiliación
  • Alshaker H; School of Medicine, University of East Anglia, Norwich, UK.
  • Wang Q; Department of Pharmacology and Biomedical Sciences, Faculty of Pharmacy and Medical Sciences, University of Petra, Amman, Jordan.
  • Kawano Y; School of Medicine, University of East Anglia, Norwich, UK.
  • Arafat T; Department of Urology, University of Kumamoto, Kumamoto, Japan.
  • Böhler T; Department of Pharmaceutical Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy and Medical Sciences, University of Petra, Amman, Jordan.
  • Winkler M; Department of Surgery and Cancer, Imperial College London, London, UK.
  • Cooper C; Department of Surgery and Cancer, Imperial College London, London, UK.
  • Pchejetski D; School of Medicine, University of East Anglia, Norwich, UK.
Oncotarget ; 7(49): 80943-80956, 2016 Dec 06.
Article en En | MEDLINE | ID: mdl-27821815
Resistance to docetaxel is a key problem in current prostate cancer management. Sphingosine kinase 1 (SK1) and phosphoinositide 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathways have been implicated in prostate cancer chemoresistance. Here we investigated whether their combined targeting may re-sensitize prostate cancer cells to docetaxel.In hormone-insensitive PC-3 and DU145 prostate cancer cells the mTOR inhibitor everolimus (RAD001) alone did not lead to significant cell death, however, it strongly sensitized cells to low levels (5 nM) of docetaxel. We show that mTOR inhibition has led to a decrease in hypoxia-inducible factor-1α (HIF-1α) protein levels and SK1 mRNA. HIF-1α accumulation induced by CoCl2 has led to a partial chemoresistance to RAD001/docetaxel combination. SK1 overexpression has completely protected prostate cancer cells from RAD001/docetaxel effects. Using gene knockdown and CoCl2 treatment we showed that SK1 mRNA expression is downstream of HIF-1α. In a human xenograft model in nude mice single RAD001 and docetaxel therapies induced 23% and 15% reduction in prostate tumor volume, respectively, while their combination led to a 58% reduction. RAD001 alone or in combination with docetaxel has suppressed intratumoral mTOR and SK1 signaling, however as evidenced by tumor size, it required docetaxel for clinical efficacy. Combination therapy was well tolerated and had similar levels of toxicity to docetaxel alone.Overall, our data demonstrate a new mechanism of docetaxel sensitization in prostate cancer. This provides a mechanistic basis for further clinical application of RAD001/docetaxel combination in prostate cancer therapy.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Protocolos de Quimioterapia Combinada Antineoplásica / Fosfotransferasas (Aceptor de Grupo Alcohol) / Taxoides / Subunidad alfa del Factor 1 Inducible por Hipoxia / Everolimus Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Protocolos de Quimioterapia Combinada Antineoplásica / Fosfotransferasas (Aceptor de Grupo Alcohol) / Taxoides / Subunidad alfa del Factor 1 Inducible por Hipoxia / Everolimus Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos